SCHEMBL4699232

SCHEMBL4699232

Oc1cccc(OCCc2ccc(Cl)cc2)c1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.52
APP P05067 1/20 0.51
CHRNB2 P17787 1/20 0.51
CHRNA4 P43681 1/20 0.51
SIRT2 Q8IXJ6 1/20 0.51
MAOA P21397 2/20 0.49
MAOB P27338 2/20 0.49
NR4A2 P43354 1/20 0.49
DRD2 P14416 1/20 0.49
DRD4 P21917 1/20 0.49
ADRA1D P25100 1/20 0.49
ADRA1A P35348 1/20 0.49
ADRA1B P35368 1/20 0.49
DRD3 P35462 1/20 0.49
FFAR1 O14842 2/20 0.47
SLC2A1 P11166 1/20 0.46
PPARD Q03181 3/20 0.46
PPARG P37231 2/20 0.46
PPARA Q07869 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31533129 0.85 APP (0.70) APPMAOAMAOBNR4A2
SCHEMBL4697290 0.85 APP (0.70) APPMAOAMAOBNR4A2
SCHEMBL25197061 0.85 DRD2 (0.65) APPCHRNB2CHRNA4SIRT2MAOA
SCHEMBL661821 0.85 DRD2 (0.65) APPCHRNB2CHRNA4SIRT2MAOA
SCHEMBL10705793 0.83 CHRNB2 (0.54) APPCHRNB2CHRNA4MAOBNR4A2
SCHEMBL25689492 0.81 GPR84 (0.52) GPR84SIRT2MAOAMAOBDRD2
SCHEMBL25236433 0.81 MAOB (0.54) GPR84SIRT2MAOAMAOBFFAR1
SCHEMBL6910779 0.81 FFAR1 (0.60) APPCHRNB2CHRNA4MAOBNR4A2
SCHEMBL13097043 0.81 LTA4H (0.53) APPCHRNB2CHRNA4DRD2DRD4
SCHEMBL25233864 0.80 ENPP2 (0.51) GPR84SIRT2MAOAMAOBNR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1926737-B1 4-AMINO-THIENO[3,2-C]PYRIDINE-7-CARBOXYLIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2017-03-15 EP disclosed
EP-1926737-A1 4-AMINO-THIENO[3,2-C]PYRIDINE-7-CARBOXYLIC ACID DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2008-06-04 EP disclosed
WO-2007031428-A1 4-AMINO-THIENO[3,2-C]PYRIDINE-7-CARBOXYLIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-03-22 WO disclosed
US-20070060607-A1 4-amino-thieno[3,2-c] pyridine-7-carboxylic acid derivatives BARTKOVITZ DAVID J 2007-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060607-A1 4-amino-thieno[3,2-c] pyridine-7-carboxylic acid derivatives BRAF, RAF1, MAP3K7 GPR84 3039/4885APP 4741/4885CHRNB2 4701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.